LexDanaLexDanabeta
Inventor

Michael Weske

Inventor
Burgdorf, DE

Overview

20→
Patents
2005–2013
Patent span
Chemistry
Primary field (CPC C)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
G01NInvestigating or analysing materials by determining their chemical or physical properties16%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms12%
A61KPreparations for medical, dental or toiletry purposes11%
C07DHeterocyclic compounds11%
C12NMicroorganisms or enzymes11%
C12YEnzymes11%
C07KPeptides7%
C07JSteroids4%
PatentTitleYear
8,435,973'17-beta HSD1 and STS inhibitors'20138,389,284'Screening and treatment methods using IGS5 enzymes of the metalloprotease family'20138,273,905'Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives'20128,030,298'17β-HSD1 and STS inhibitors'20118,012,471'Screening and treatment methods using IGS5 enzymes of the metalloprotease family'20117,714,150'Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives'20107,534,903'Use of amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl-compounds in the treatment of cardiac arrhythmia and other disease states'20097,452,875'Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them'20087,427,611'Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them'20087,410,962'Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them'20087,368,582'Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them'20087,312,321'Antibody to human enzymes of the metalloprotease family'20077,282,325'Method of preparing pharmaceutical compositions'20077,262,184'Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them'20077,238,470'Method of treating or inhibiting obesity'20077,232,813'Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders'20077,189,525'Human enzymes of the metalloprotease family'20077,083,965'Human enzymes of the metalloprotease family'20066,946,243'Method of identifying compounds suitable for treatment and/or prophylaxis of obesity'20056,855,532'Human enzymes of the metalloprotease family'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005–2010Patents assigned to SOLVAY PHARM GMBH (10)· patent assignee history
2005–2007Patents assigned to SOLVAY PHARM BV (5)· patent assignee history
2005–2013Based in Burgdorf, DE· patent location history
2005–2007Based in Weesp, NL· patent location history
2011–2013Patents assigned to ABBOTT PRODUCTS GMBH (3)· patent assignee history
2011–2013Patents assigned to ABBOTT HEALTHCARE PRODUCTS BV (2)· patent assignee history
2012–2013Patents assigned to WESKE MICHAEL (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SOLVAY PHARM GMBH102005–2010
SOLVAY PHARM BV52005–2007
ABBOTT PRODUCTS GMBH32011–2013
WESKE MICHAELself32012–2013
ABBOTT HEALTHCARE PRODUCTS BV22011–2013
Locations
LocationPatentsSpan
Burgdorf, DE152005–2013
Weesp, NL52005–2007